Potential protective factors such as eosinophilia, Th2-skewed immune response, reduced ACE-2 expression, and the use of inhaled corticosteroids, may have contributed to the more favorable outcomes seen in asthmatic patients with COVID-19. The gene discussed is ACE2; the disease is COVID-19.